Medpace Holdings (NASDAQ: MEDP) reported Q2 EPS of $4.25, $0.27 better than the analyst estimate of $3.98. Revenue for the quarter came in at $707.3 million versus the consensus estimate of $690.68 million.

GUIDANCE:

Medpace Holdings sees FY2026 EPS of $17.25-$17.95, versus the consensus of $17.12. Medpace Holdings sees FY2026 revenue of $2.805-2.885 million, versus the consensus of $2.772 million.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.